Neferine protects endothelial cells against damages induced by LPC and relationship with asymmetric dimethylarginine

Zhongguo Zhongyao Zazhi

Volumn 33, Issue 21, 2008, Pages 2526-2529

  Zhang, Sai Dan ^a   Peng, Zhen Yu ^a   Liu, Shao ^a   Pei, Zhi Fang ^a   Chen, Feng ^a   Yang, Liu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Endothelial cell; Lipid peroxidation; Lysophosphatidylcholine; Neferine

Indexed keywords

ARGININE; BENZYLISOQUINOLINE DERIVATIVE; DRUG DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; MALONALDEHYDE; NEFERINE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL LINE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; METABOLISM;

ARGININE; BENZYLISOQUINOLINES; CELL LINE; ENDOTHELIAL CELLS; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MALONDIALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 57249111708     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis[J]. Circulation, 2004, 109(23):III27.
2. Boger R H. Association of asymmetric dimethylarginine and endothelial dysfunction [J]. Clin Chem Lab Med, 2003 ,41(11): 1467.
3. Boger R H, Sydow K, Borlak J, et al. LDL cholesterol upregulates synthesis of asymetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependentm ethyltransferases[J]. Circ Res, 2000,87(2):99.
4. Chinese source
5. Chinese source
6. Grafe M, Auch-Schwelk W, Hertel H, et al. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL[J]. Atherosclerosis, 1998, 137 (2):87.
7. Watanabe T, Pakala R, Katagiri T, et al. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation [J]. J Cardiovasc Pharmacol, 2002, 39(3):449.
8. Paroni R, Fermo I, Fiorina P, et al. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects[J]. Amino Acids, 2005, 28(4) :389.
9. Curgunlu A, Uzun H, Bavunoglu I, et al. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension[J]. J Hum Hypertens, 2005,19(8):629.
10. Boger R H, Bode-Boger S M, Sydow K, et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst (e) inemia or hypercholesterolemia [J]. Arterioscler Thromb Vase Biol, 2000, 20(6):1557.
11. Chinese source
12. Jia S J, Jiang D J, Hu C P, et al. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells [J]. Vascul Pharmacol, 2006, 44(3):143.
13. Jiang J L, Li N S, Li Y J. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level[J]. Br J Pharmacol, 2002, 135(5):1175.
14. Tan B, Jiang D J, Huang H, et al. Taurine protects against low-density lipoprotein induced endothelial dysfunction by the DDAH/ADMA pathway [J]. Vascul Pharmacol, 2007, 46 (5) : 338.